Percheron Therapeutics COO Dr Anthony Filippis Updates JustStocks On Partnering for ATL1102

Поділитися
Вставка
  • Опубліковано 22 лип 2024
  • Percheron Therapeutics Limited (ASX:PER) chief operating officer Dr Anthony Filippis discusses with JustStocks Video the company's strategy for partnering on its lead program ATL1102 and how those discussions are progressing.

КОМЕНТАРІ •